Results 1 to 10 of about 825,494 (348)

Long-term response to second-line afatinib treatment for advanced squamous cell carcinoma non-small cell lung cancer: a rare case report. [PDF]

open access: yesJ Int Med Res, 2020
The ErbB family is composed of four cell membrane receptors: ErbB-1 (epidermal growth factor receptor or human epidermal growth factor receptor [HER]1), ErbB-2 (HER2), ErbB-3 (HER3), and ErbB-4 (HER4).
Sun M   +7 more
europepmc   +2 more sources

Targeted therapy of non-small-cell lung carcinoma [PDF]

open access: yesTherapeutic Advances in Respiratory Disease, 2012
The rapid expansion of novel technologies in cancer research over the past several years has led to a dramatically improved understanding of the molecular biology of lung cancer. As a consequence, novel targeted therapies are rapidly being developed.
Divya Tiwari   +2 more
doaj   +3 more sources

Case Report: Pathological diagnosis of left upper lobe nodules: two cases of composite small cell lung cancer and literature review [PDF]

open access: yesFrontiers in Oncology
Combined Small Cell Lung Cancer (C-SCLC) is defined by the World Health Organization (WHO) as a combination of Small Cell Lung Cancer (SCLC) and other components, which may include any type of Non-Small Cell Lung Cancer (NSCLC).
Jishen Zhang   +3 more
doaj   +2 more sources

Cetuximab and biomarkers in non-small-cell lung carcinoma

open access: yesBiologics: Targets & Therapy, 2012
Nitin Patil, Mohammed Abba, Heike AllgayerDepartment of Experimental Surgery, Medical Faculty Mannheim, University of Heidelberg and Molecular Oncology of Solid Tumors Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyAbstract: Cancer ...
Patil N, Abba M, Allgayer H
doaj   +4 more sources

Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma

open access: yesNature Communications, 2023
TGF-β stimulated tumor-associated neutrophils (TANs) can exert pro-tumoral functions. Here the authors show that Smad3 activation in TANs is associated with an N2-like polarization state and poor outcome in patients with non-small cell lung carcinoma and
J. Chung   +14 more
semanticscholar   +1 more source

Diagnostic Utility of TTF-1 and P40 Immunohistochemical Markers for Subtyping of Non-Small Cell Lung Carcinoma

open access: yesJournal of Medical Sciences and Health, 2023
Background : Lung cancer is the leading cause of cancer-related mortality over worldwide. Although the pathological diagnosis of lung carcinoma is limited as only small specimen available for diagnosis, the availability of targeted therapies has
Mayank Agrawal   +4 more
doaj   +1 more source

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma

open access: yesInternational Journal of Molecular Sciences, 2021
Lung cancer is one of the most common malignant neoplasms. As a result of the disease’s progression, patients may develop metastases to the central nervous system.
Agnieszka Rybarczyk-Kasiuchnicz   +2 more
semanticscholar   +1 more source

Lung: Non-small cell carcinoma [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
Non-small cell carcinomas are divided into three main categories according to the predominant morphology of the tumour cells as determined by light microscopy. Although it is possible to distinguish different histological sub-groups in this way, or by using gene expression profiling, treatment is currently decided on the basis of tumour staging, age ...
J Heighway, DC Betticher
openaire   +1 more source

Home - About - Disclaimer - Privacy